These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 18348208)
41. Total lymphocyte count: a surrogate marker for predicting CD4+ count in enrolled process for antiretroviral therapy in resource-limited settings. Susaengrat W; Mitchai M; Leerattanapetch N J Med Assoc Thai; 2008 Oct; 91(10):1514-7. PubMed ID: 18972893 [TBL] [Abstract][Full Text] [Related]
42. The need for standardization in laboratory networks. Peter TF; Shimada Y; Freeman RR; Ncube BN; Khine AA; Murtagh MM Am J Clin Pathol; 2009 Jun; 131(6):867-74. PubMed ID: 19461096 [TBL] [Abstract][Full Text] [Related]
43. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations. Pinheiro Edos S; Antunes OA; Fortunak JM Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246 [TBL] [Abstract][Full Text] [Related]
44. Emerging technologies in point-of-care molecular diagnostics for resource-limited settings. Peeling RW; McNerney R Expert Rev Mol Diagn; 2014 Jun; 14(5):525-34. PubMed ID: 24784765 [TBL] [Abstract][Full Text] [Related]
45. Task shifting in HIV/AIDS: opportunities, challenges and proposed actions for sub-Saharan Africa. Zachariah R; Ford N; Philips M; Lynch S; Massaquoi M; Janssens V; Harries AD Trans R Soc Trop Med Hyg; 2009 Jun; 103(6):549-58. PubMed ID: 18992905 [TBL] [Abstract][Full Text] [Related]
46. Results of a rapid HIV screening and diagnostic testing program in an urban emergency department. White DA; Scribner AN; Schulden JD; Branson BM; Heffelfinger JD Ann Emerg Med; 2009 Jul; 54(1):56-64. PubMed ID: 18990468 [TBL] [Abstract][Full Text] [Related]
48. Sequence-specific detection method for reverse transcription, loop-mediated isothermal amplification of HIV-1. Curtis KA; Rudolph DL; Owen SM J Med Virol; 2009 Jun; 81(6):966-72. PubMed ID: 19382260 [TBL] [Abstract][Full Text] [Related]
49. Point of care testing. Nichols JH Clin Lab Med; 2007 Dec; 27(4):893-908, viii. PubMed ID: 17950904 [TBL] [Abstract][Full Text] [Related]
50. Implementation of HIV and Tuberculosis Diagnostics: The Importance of Context. Dominique JK; Ortiz-Osorno AA; Fitzgibbon J; Gnanashanmugam D; Gilpin C; Tucker T; Peel S; Peter T; Kim P; Smith S Clin Infect Dis; 2015 Oct; 61Suppl 3(Suppl 3):S119-25. PubMed ID: 26409272 [TBL] [Abstract][Full Text] [Related]
51. Affordable diagnostics--changing the paradigm in India. Manian BS Cytometry B Clin Cytom; 2008; 74 Suppl 1():S117-22. PubMed ID: 18271018 [TBL] [Abstract][Full Text] [Related]
52. Point-of-care diagnostics for global health. Yager P; Domingo GJ; Gerdes J Annu Rev Biomed Eng; 2008; 10():107-44. PubMed ID: 18358075 [TBL] [Abstract][Full Text] [Related]
53. Evaluating operational specifications of point-of-care diagnostic tests: a standardized scorecard. Lehe JD; Sitoe NE; Tobaiwa O; Loquiha O; Quevedo JI; Peter TF; Jani IV PLoS One; 2012; 7(10):e47459. PubMed ID: 23118871 [TBL] [Abstract][Full Text] [Related]
54. The use of Minilabs to improve the testing capacity of regulatory authorities in resource limited settings: Tanzanian experience. Risha PG; Msuya Z; Clark M; Johnson K; Ndomondo-Sigonda M; Layloff T Health Policy; 2008 Aug; 87(2):217-22. PubMed ID: 18282632 [TBL] [Abstract][Full Text] [Related]
55. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes. Land KJ; Boeras DI; Chen XS; Ramsay AR; Peeling RW Nat Microbiol; 2019 Jan; 4(1):46-54. PubMed ID: 30546093 [TBL] [Abstract][Full Text] [Related]
56. Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. Schito M; Peter TF; Cavanaugh S; Piatek AS; Young GJ; Alexander H; Coggin W; Domingo GJ; Ellenberger D; Ermantraut E; Jani IV; Katamba A; Palamountain KM; Essajee S; Dowdy DW J Infect Dis; 2012 May; 205 Suppl 2(Suppl 2):S169-80. PubMed ID: 22457286 [TBL] [Abstract][Full Text] [Related]
57. Point-of-care diagnostics: will the hurdles be overcome this time? Huckle D Expert Rev Med Devices; 2006 Jul; 3(4):421-6. PubMed ID: 16866639 [TBL] [Abstract][Full Text] [Related]
58. Developing laboratory systems and infrastructure for HIV scale-up: A tool for health systems strengthening in resource-limited settings. Justman JE; Koblavi-Deme S; Tanuri A; Goldberg A; Gonzalez LF; Gwynn CR J Acquir Immune Defic Syndr; 2009 Nov; 52 Suppl 1():S30-3. PubMed ID: 19858935 [TBL] [Abstract][Full Text] [Related]
59. Point-of-Care Diagnostics in Low Resource Settings: Present Status and Future Role of Microfluidics. Sharma S; Zapatero-RodrÃguez J; Estrela P; O'Kennedy R Biosensors (Basel); 2015 Aug; 5(3):577-601. PubMed ID: 26287254 [TBL] [Abstract][Full Text] [Related]
60. Rapid Low-Cost Microfluidic Detection in Point of Care Diagnostics. Raju SP; Chu X J Med Syst; 2018 Aug; 42(10):184. PubMed ID: 30167799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]